Recombinant CHO (Chinese hamster ovary) cell lines producing therapeutic proteins often lose their production capability during long-term cultivation. To ensure that CHO production cell lines can be up-scaled to high volume bioreactors labor intensive stability studies of several months have to be performed to deselect clones that are losing productivity over time. The ability to predict whether clones will produce recombinant proteins at constant high levels e.g. through determination of biomarkers such as expression of specific genes, plasmid integration sites or epigenetic patterns, or even to improve CHO host cell lines to increase the probability of the generation of stable clones would be highly beneficial. Previously, we reported tha...
Mammalian cells act as an ideal host for the production of recombinant proteins and therapeutics, wi...
Productivity and stability are critical for the protein drug producing cell lines for manufacturing....
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
Recombinant CHO (Chinese hamster ovary) cell lines producing therapeutic proteins often lose their p...
Chinese Hamster Ovary (CHO) cells are widely used for large scale production of recombinant biopharm...
Recently, we reported that the loss of a telomeric region of chromosome 8 in Chinese Hamster Ovary (...
Chinese hamster ovary (CHO) cells are the most widely used host for large scale production of recomb...
Chinese hamster ovary (CHO) cells are the preferred and most widely used cell line for biopharmaceut...
Chinese hamster ovary (CHO) cells are the preferred and most widely used cell line for biopharmaceut...
While many perceive mammalian cell culture-based manufacturing for biopharmaceuticals an established...
A basic goal in the development of recombinant proteins is the generation of cell lines that express...
Chinese hamster ovary (CHO) cells are a source of multi-ton quantities of protein pharmaceuticals. T...
Chinese hamster ovary (CHO) cell lines are widely used in the pharmaceutical industry to produce the...
Chinese hamster ovary (CHO) cells comprise a variety of lineages, including CHO-DXB11, CHO-K1, CHO-D...
Chinese Hamster Ovary (CHO) cells are widely used in biopharmaceutical production. Improvements to c...
Mammalian cells act as an ideal host for the production of recombinant proteins and therapeutics, wi...
Productivity and stability are critical for the protein drug producing cell lines for manufacturing....
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
Recombinant CHO (Chinese hamster ovary) cell lines producing therapeutic proteins often lose their p...
Chinese Hamster Ovary (CHO) cells are widely used for large scale production of recombinant biopharm...
Recently, we reported that the loss of a telomeric region of chromosome 8 in Chinese Hamster Ovary (...
Chinese hamster ovary (CHO) cells are the most widely used host for large scale production of recomb...
Chinese hamster ovary (CHO) cells are the preferred and most widely used cell line for biopharmaceut...
Chinese hamster ovary (CHO) cells are the preferred and most widely used cell line for biopharmaceut...
While many perceive mammalian cell culture-based manufacturing for biopharmaceuticals an established...
A basic goal in the development of recombinant proteins is the generation of cell lines that express...
Chinese hamster ovary (CHO) cells are a source of multi-ton quantities of protein pharmaceuticals. T...
Chinese hamster ovary (CHO) cell lines are widely used in the pharmaceutical industry to produce the...
Chinese hamster ovary (CHO) cells comprise a variety of lineages, including CHO-DXB11, CHO-K1, CHO-D...
Chinese Hamster Ovary (CHO) cells are widely used in biopharmaceutical production. Improvements to c...
Mammalian cells act as an ideal host for the production of recombinant proteins and therapeutics, wi...
Productivity and stability are critical for the protein drug producing cell lines for manufacturing....
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...